113 related articles for article (PubMed ID: 23479318)
1. Association of cadmium and lead with antioxidant status and incidence of benign prostatic hyperplasia in patients of Western India.
Pandya C; Gupta S; Pillai P; Bhandarkar A; Khan A; Bhan A; Prajapati A; Gupta S
Biol Trace Elem Res; 2013 Jun; 152(3):316-26. PubMed ID: 23479318
[TBL] [Abstract][Full Text] [Related]
2. Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma.
Guzel S; Kiziler L; Aydemir B; Alici B; Ataus S; Aksu A; Durak H
Biol Trace Elem Res; 2012 Jan; 145(1):23-32. PubMed ID: 21809052
[TBL] [Abstract][Full Text] [Related]
3. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1 gene polymorphism and heavy metal analyses in benign prostatic hyperplasia and prostate cancer: An explorative case-control study.
Singh V; Madeshiya AK; Ansari NG; Singh MK; Abhishek A
Urol Oncol; 2023 Aug; 41(8):355.e9-355.e17. PubMed ID: 37277283
[TBL] [Abstract][Full Text] [Related]
6. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
7. Systemic stress responses in patients undergoing surgery for benign prostatic hyperplasia.
Ruzic B; Tomaskovic I; Trnski D; Kraus O; Bekavac-Beslin M; Vrkic N
BJU Int; 2005 Jan; 95(1):77-80. PubMed ID: 15638899
[TBL] [Abstract][Full Text] [Related]
8. [Relation between benign prostatic hyperplasia and obesity and estrogen].
Matsuda T; Abe H; Suda K
Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study on prostatic cancer detected incidentally by transurethral resection of the prostate].
Hayakawa T; Mitsuya H; Kojima M; Hayase Y
Hinyokika Kiyo; 2002 Jan; 48(1):13-6. PubMed ID: 11868378
[TBL] [Abstract][Full Text] [Related]
11. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
12. Removal and accumulation of cadmium and lead by Typha latifolia exposed to single and mixed metal solutions.
Alonso-Castro AJ; Carranza-Alvarez C; Alfaro-De la Torre MC; Chávez-Guerrero L; García-De la Cruz RF
Arch Environ Contam Toxicol; 2009 Nov; 57(4):688-96. PubMed ID: 19536587
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiology and natural course of benign prostatic hyperplasia].
Blom JH; Schröder FH
Urologe A; 1992 May; 31(3):129-34. PubMed ID: 1377429
[TBL] [Abstract][Full Text] [Related]
14. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia.
Shin IS; Lee MY; Jung DY; Seo CS; Ha HK; Shin HK
Food Chem Toxicol; 2012 Mar; 50(3-4):884-8. PubMed ID: 22266360
[TBL] [Abstract][Full Text] [Related]
15. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Ma W; Zeng G; Qi D
J Surg Oncol; 2011 Nov; 104(6):672-8. PubMed ID: 21674503
[TBL] [Abstract][Full Text] [Related]
16. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia.
Aydin A; Arsova-Sarafinovska Z; Sayal A; Eken A; Erdem O; Erten K; Ozgök Y; Dimovski A
Clin Biochem; 2006 Feb; 39(2):176-9. PubMed ID: 16413012
[TBL] [Abstract][Full Text] [Related]
18. Watchful waiting in benign prostatic hyperplasia.
Wiygul J; Babayan RK
Curr Opin Urol; 2009 Jan; 19(1):3-6. PubMed ID: 19057209
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
[TBL] [Abstract][Full Text] [Related]
20. Two-year outcome of high-risk benign prostate hyperplasia patients treated with transurethral prostate resection by plasmakinetic or conventional procedure.
Lv L; Wang L; Fan M; Ju W; Pang Z; Zhu Z; Li B; Xiao Y; Zeng F
Urology; 2012 Aug; 80(2):389-94. PubMed ID: 22698467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
